Avita Medical vs Tela Bio
Avita Medical and Tela Bio are similar in size: $71.6m and $80.3m of revenue in their latest fiscal years. Tela Bio grew faster (15.8% against 11.5%). Tela Bio kept more of each dollar of sales as profit: a net margin of -48.4% against -67.8%.
| Latest fiscal year | Avita MedicalRCEL, 2025 | Tela BioTELA, 2025 |
|---|---|---|
| Revenue | $71.6m | $80.3m |
| Revenue growth | 11.5% | 15.8% |
| Net income | −$48.6m | −$38.8m |
| Operating margin | -59.4% | -42.0% |
| Net margin | -67.8% | -48.4% |
| Return on equity | — | — |
| Free cash flow | −$32.2m | −$28.7m |
| Cash | $10.2m | $50.8m |
| Total debt | $43.0m | $55.7m |
| Debt to equity | — | 881.6% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 226 | 150 |
| Market value | $477m | $35.2m |
| Price vs our value range | — | — |
| Moat score | 29 (Weak) | 34 (Weak) |
| Insider trades, 12 months | 14 buys, 0 sales | 7 buys, 0 sales |